Moreover, ET-1 plays a pivotal role in the pathogenesis of antineoplastic drug-induced hypertension, as well as being a crucial pathway involved in VEGF inhibitor-induced hypertension and renal damage (Facemire et al., 2009; Kappers et al., 2012). This evidence concerns the gene EDN1 and hypertensive disorder.